Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haojie Huang

Showing results (1-10 of 255) with videos related to

Pageof 26
Sort By:
Journal of the National Cancer Center|February 25, 2026
Decoding prostate cancer therapy resistance and novel therapeutic strategiesHaojie Huang
Asian Journal of Andrology|October 1, 2013
Scaffold attachment factor B1: an intrinsic inhibitor of androgen receptor downregulated in prostate cancerHaojie Huang
Cell Cycle (Georgetown, Tex.)|October 15, 2013
EZH2 takes the stage when BRCA1 losesLan Wang, Haojie Huang
Molecular and Cellular Pharmacology|April 27, 2010
Targeting the Androgen Receptor by Taxol in Castration-Resistant Prostate CancerJingting Jiang, Haojie Huang
Advances in Experimental Medicine and Biology|January 5, 2020
Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate CancerYuqian Yan, Haojie Huang
Journal of the National Cancer Center|February 25, 2026
Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancerYujun Shuai, Haojie Huang
Current Drug Targets|March 30, 2011
FOXO1: a potential target for human diseasesHuarui Lu, Haojie Huang
Cancer Cell|August 12, 2020
Microenvironment-Mediated Resistance to Anti-Androgen TherapyJacob J Orme, Haojie Huang
Critical Reviews in Eukaryotic Gene Expression|November 27, 2002
The role of the androgen receptor in prostate cancerHaojie Huang, Donald J Tindall
Future Oncology (London, England)|March 25, 2006
FOXO factors: a matter of life and deathHaojie Huang, Donald J Tindall
Pageof 26

Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Journal of the National Cancer Center|February 25, 2026
Decoding prostate cancer therapy resistance and novel therapeutic strategiesHaojie Huang
Asian Journal of Andrology|October 1, 2013
Scaffold attachment factor B1: an intrinsic inhibitor of androgen receptor downregulated in prostate cancerHaojie Huang
Cell Cycle (Georgetown, Tex.)|October 15, 2013
EZH2 takes the stage when BRCA1 losesLan Wang, Haojie Huang
Molecular and Cellular Pharmacology|April 27, 2010
Targeting the Androgen Receptor by Taxol in Castration-Resistant Prostate CancerJingting Jiang, Haojie Huang
Advances in Experimental Medicine and Biology|January 5, 2020
Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate CancerYuqian Yan, Haojie Huang
Journal of the National Cancer Center|February 25, 2026
Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancerYujun Shuai, Haojie Huang
Current Drug Targets|March 30, 2011
FOXO1: a potential target for human diseasesHuarui Lu, Haojie Huang
Cancer Cell|August 12, 2020
Microenvironment-Mediated Resistance to Anti-Androgen TherapyJacob J Orme, Haojie Huang
Critical Reviews in Eukaryotic Gene Expression|November 27, 2002
The role of the androgen receptor in prostate cancerHaojie Huang, Donald J Tindall
Future Oncology (London, England)|March 25, 2006
FOXO factors: a matter of life and deathHaojie Huang, Donald J Tindall
Pageof 26